Search by Drug Name or NDC
NDC 61570-0112-01 ALTACE 5 mg/1 Details
ALTACE 5 mg/1
ALTACE is a ORAL CAPSULE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Pfizer Laboratories Div Pfizer Inc. The primary component is RAMIPRIL.
MedlinePlus Drug Summary
Ramipril is used alone or in combination with other medications to treat high blood pressure. It is also used to reduce the risk of heart attack and stroke in patients at risk for these problems and to improve survival in patients with heart failure after a heart attack. Ramipril is in a class of medications called angiotensin-converting enzyme (ACE) inhibitors. It works by decreasing certain chemicals that tighten the blood vessels, so blood flows more smoothly and the heart can pump blood more efficiently. High blood pressure is a common condition and when not treated, can cause damage to the brain, heart, blood vessels, kidneys, and other parts of the body. Damage to these organs may cause heart disease, a heart attack, heart failure, stroke, kidney failure, loss of vision, and other problems. In addition to taking medication, making lifestyle changes will also help to control your blood pressure. These changes include eating a diet that is low in fat and salt, maintaining a healthy weight, exercising at least 30 minutes most days, not smoking, and using alcohol in moderation.
Related Packages: 61570-0112-01Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Ramipril
Product Information
| NDC | 61570-0112 |
|---|---|
| Product ID | 61570-112_ac92039f-c6f1-4099-bc12-b0df7a16d179 |
| Associated GPIs | 36100050000130 |
| GCN Sequence Number | 015941 |
| GCN Sequence Number Description | ramipril CAPSULE 5 MG ORAL |
| HIC3 | A4D |
| HIC3 Description | ANTIHYPERTENSIVES, ACE INHIBITORS |
| GCN | 48543 |
| HICL Sequence Number | 006080 |
| HICL Sequence Number Description | RAMIPRIL |
| Brand/Generic | Brand |
| Proprietary Name | ALTACE |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | ramipril |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | CAPSULE |
| Route | ORAL |
| Active Ingredient Strength | 5 |
| Active Ingredient Units | mg/1 |
| Substance Name | RAMIPRIL |
| Labeler Name | Pfizer Laboratories Div Pfizer Inc |
| Pharmaceutical Class | Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA] |
| DEA Schedule | n/a |
| Marketing Category | NDA |
| Application Number | NDA019901 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 61570-0112-01 (61570011201)
| NDC Package Code | 61570-112-01 |
|---|---|
| Billing NDC | 61570011201 |
| Package | 100 CAPSULE in 1 BOTTLE (61570-112-01) |
| Marketing Start Date | 1991-01-28 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |